Published Medical Microbial Mediators UCLA researchers have identified a strategy to manipulate the gut microbiome to mimic the effects of a ketogenic diet, as a treatment for CNS disorders and metabolic diseases. By University of California, Los Angeles
Published Healthcare & Pharmaceuticals ACE2 Peptide Agonist for CKD ACE2 agonist with anti-fibrotic and anti-inflammatory activity, and that controls blood glucose levels in diabetic mouse models; potential to treat diabetic organ disease. By The University of Queensland
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
